Home > Healthcare > Biotechnology > Biotechnology R&D > Exosomes Market
Exosomes Market size was valued to be USD 250.8 million in 2022 and is expected to reach USD 3.2 billion in 2032 with a CAGR of 29.9% from 2023 to 2032. The market's significant growth is primarily driven by the rising cases of cancer worldwide.
The growing prevalence of cancer patients directly impacts the increased demand for exosomes, as they are used as cancer biomarkers for early detection and diagnosis. Also, increasing technological advancements in exosome isolation is a significant driving factor for the expansion of the exosome market. For instance, in November 2022, Cell Guidance Systems introduced its Instant Exosomes and LipoQ assay products. LipoQ is a lipid quantification test, and the Instant Exosomes are freeze-dried exosomes. They are used for assay calibration, protein marker analysis and as biomarkers in cancer diagnostics. Such advancements are anticipated to increase the use of exosomes for research and spur the industrial expansion.
Exosomes are small, membrane-bound vesicles that are secreted by various cell types, including both normal and pathological cells, such as cancer cells. They are a type of extracellular vesicle and are typically in the range of 30 to 150 nanometres in diameter. Exosomes play a crucial role in cell-to-cell communication by carrying a diverse cargo of bioactive molecules, including proteins, lipids, nucleic acids (such as RNA and DNA), and other biomolecules.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Exosomes Market Size in 2022: | USD 250.8 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 29.9% |
2032 Value Projection: | USD 3.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 170 |
Tables, Charts & Figures: | 314 |
Segments covered: | Products & Services, Application, Indication, End-users, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|